Koers Biocept Inc Nasdaq
Aandelen
US09072V1052
Medische apparatuur, benodigdheden & distributie
Omzet 2021 | 61,25 mln. 57,18 mln. | Omzet 2022 | 25,86 mln. 24,14 mln. | Marktkapitalisatie | 9,04 mln. 8,44 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -2 mln. -1,87 mln. | Nettowinst (verlies) 2022 | -32 mln. -29,87 mln. | EV/omzet 2021 | 0,73 x |
Nettoliquiditeiten 2021 | 16,19 mln. 15,12 mln. | Nettoliquiditeiten 2022 | 788K 736K | EV/omzet 2022 | 0,32 x |
K/w-verhouding 2021 |
-18,9
x | K/w-verhouding 2022 |
-0,28
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 100% |
Recentste transcriptie over Biocept Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Barbara Blouw
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-20 |
Nathaniel Sweed
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 60 | 08-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,60% | 12,63 mld. | |
-9,59% | 7,67 mld. | |
+1,82% | 5,42 mld. | |
+0,02% | 4,57 mld. | |
-51,89% | 3,51 mld. | |
+6,42% | 2,59 mld. | |
-14,59% | 2,05 mld. | |
-8,29% | 1,79 mld. | |
+1,67% | 1,77 mld. |